Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1995 Oct;79(10):922–925. doi: 10.1136/bjo.79.10.922

Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment.

B C Polak 1, G S Baarsma 1, B Snyers 1
PMCID: PMC505294  PMID: 7488581

Abstract

AIMS/BACKGROUND--This study was undertaken to confirm the association between diffuse retinal pigment epitheliopathy (DRPE) and systemic corticosteroid therapy. This finding can be of help in determining an aetiological factor in DRPE and associated diseases. Corticosteroids may contribute to the development of leakage in the presence of a retinal pigment epitheliopathy or central serous chorioretinopathy. METHODS--Cases of DRPE were collected from the files of members of the European Fluorescein Angiography Club. There were 34 who developed their ophthalmic symptoms while being treated with corticosteroids. RESULTS--DRPE developed in 34 patients from 10 European eye clinics during systemic treatment with corticosteroids. Thirteen patients were treated with corticosteroids after allotransplantation, 21 other patients developed ocular symptoms while treated with steroids for serious systemic disorders. Symptoms occurred in some patients when the daily corticosteroid dosage was elevated, and the visual complaints ameliorated or even disappeared sometimes on discontinuation of the corticosteroid therapy. CONCLUSION--Corticosteroids can damage the retinal pigment epithelial barrier and predispose a patient to serous retinal detachment, whereas psychological stress may play a role in the development of central serous chorioretinopathy. A decrease of the daily corticosteroid dosage may help to diminish the visual symptoms.

Full text

PDF
922

Images in this article

924Image
on p.924
924Image
on p.924
924Image
on p.924
924Image
on p.924
924Image
on p.924

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bouzas E. A., Scott M. H., Mastorakos G., Chrousos G. P., Kaiser-Kupfer M. I. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol. 1993 Sep;111(9):1229–1233. doi: 10.1001/archopht.1993.01090090081024. [DOI] [PubMed] [Google Scholar]
  2. Chumbley L. C., Frank R. N. Central serous retinopathy and pregnancy. Am J Ophthalmol. 1974 Feb;77(2):158–160. doi: 10.1016/0002-9394(74)90667-9. [DOI] [PubMed] [Google Scholar]
  3. Cruysberg J. R., Deutman A. F. Visual disturbances during pregnancy caused by central serous choroidopathy. Br J Ophthalmol. 1982 Apr;66(4):240–241. doi: 10.1136/bjo.66.4.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Friberg T. R., Eller A. W. Serous retinal detachment resembling central serous chorioretinopathy following organ transplantation. Graefes Arch Clin Exp Ophthalmol. 1990;228(4):305–309. doi: 10.1007/BF00920052. [DOI] [PubMed] [Google Scholar]
  5. Gass J. D. Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol. 1991 May;109(5):677–681. doi: 10.1001/archopht.1991.01080050091036. [DOI] [PubMed] [Google Scholar]
  6. Gass J. D., Slamovits T. L., Fuller D. G., Gieser R. G., Lean J. S. Posterior chorioretinopathy and retinal detachment after organ transplantation. Arch Ophthalmol. 1992 Dec;110(12):1717–1722. doi: 10.1001/archopht.1992.01080240057030. [DOI] [PubMed] [Google Scholar]
  7. Jain I. S., Singh K. Maculopathy a corticosteroid side-effect. J All India Ophthalmol Soc. 1966 Dec;14(6):250–252. [PubMed] [Google Scholar]
  8. Polak B. C. Ophthalmological complications of haemodialysis and kidney transplantation. Doc Ophthalmol. 1980 May 30;49(1):v-vii, 1-96. doi: 10.1007/BF00175176. [DOI] [PubMed] [Google Scholar]
  9. Snyers B., Kestens C. Choroïdite séreuse centrale après transplantation rénale. Bull Soc Belge Ophtalmol. 1990;239:87–101. [PubMed] [Google Scholar]
  10. Sunness J. S., Haller J. A., Fine S. L. Central serous chorioretinopathy and pregnancy. Arch Ophthalmol. 1993 Mar;111(3):360–364. doi: 10.1001/archopht.1993.01090030078043. [DOI] [PubMed] [Google Scholar]
  11. Wakakura M., Ishikawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol. 1984 May;68(5):329–331. doi: 10.1136/bjo.68.5.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Williamson J., Nuki G. Macular lesions during systemic therapy with depot tetracosactrin. Br J Ophthalmol. 1970 Jun;54(6):405–409. doi: 10.1136/bjo.54.6.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Yannuzzi L. A. Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc. 1986;84:799–845. [PMC free article] [PubMed] [Google Scholar]
  14. Yoshioka H., Katsume Y., Akune H. Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings. Ophthalmologica. 1982;185(3):168–178. doi: 10.1159/000309239. [DOI] [PubMed] [Google Scholar]
  15. Yoshioka H., Katsume Y. Experimental central serous chorioretinopathy. III: ultrastructural findings. Jpn J Ophthalmol. 1982;26(4):397–409. [PubMed] [Google Scholar]
  16. von Winning C. H., Oosterhuis J. A., Renger-van Dijk A. H., Hornstra-Limburg H., Polak B. C. Diffuse retinal pigment epitheliopathy. Ophthalmologica. 1982;185(1):7–14. doi: 10.1159/000309216. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES